ROBINSON MATTHEW K 4
4 · Immunome Inc. · Filed Jun 21, 2022
Insider Transaction Report
Form 4
Immunome Inc.IMNM
ROBINSON MATTHEW K
Chief Technology Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-06-16+35,000→ 35,000 totalExercise: $3.42Exp: 2032-06-16→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the options vest on June 16, 2023, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter.